Osteoarthritis and Chondrocytes: On the Road from Mechanisms to Treatment
Journal of Dental Research · 2026-04 · 105 (4) · 432-442
DOI: 10.1177/00220345251385964 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Dental Research, online erschienen am 26.11.2025. Verfasst von J T Huh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cartilage Biology and Regenerative Medicine Laboratory, Section of Growth and Development, Division of Orthodontics, College of Dental Medicine, Colu…. Hauptthemen laut MEDLINE: Chondrocytes, Osteoarthritis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCR NIH HHS, National Institute of Dental and Craniofacial Research.
Abstract (Originalsprache)
Osteoarthritis (OA) is a degenerative whole-joint disease affecting more than 500 million people worldwide, characterized by irreversible tissue loss, chronic pain, and physical disability. The pathogenesis of OA is complex, with risk factors such as age, obesity, and injury contributing to a disruption of cartilage homeostasis. Here we focus on the chondrocyte, the sole mature cell type in cartilage, as an active participant in mediating joint demise rather than a mere casualty. In a healthy joint, chondrocytes are quiescent, but in the OA environment, they transition to a dysfunctional, catabolic state, undergoing pathological changes such as hypertrophy and senescence that drive tissue degradation. The canonical Wnt signaling pathway is a critical regulator of cartilage maintenance, and its dysregulation is a key driver of OA progression, making it a prime therapeutic target. However, translating this knowledge into effective disease-modifying OA drugs (DMOADs) has been challenging. While experimental DMOADs have shown promise, many have faced setbacks in clinical trials. These trials underscore the complexity of OA and highlight the critical need for improved trial design that stratifies patients based on disease stage and structural characteristics. Comparing the pathobiology of different joints, such as the knee and temporomandibular joint (TMJ), further reveals how joint-specific differences in biomechanics and cellular composition can dictate therapeutic responses. Among emerging strategies, Wnt-targeted therapies that stabilize the joint microenvironment by suppressing inflammation and promoting chondrocyte survival hold significant promise. This review consolidates the evidence positioning the chondrocyte as an active driver of OA pathogenesis, rather than a passive casualty, to inform future therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cartilage Biology and Regenerative Medicine Laboratory, Section of Growth and Development, Division of Orthodontics, College of Dental Medicine, Columbia University Irving Medical Center, New York, NY, USA.
ORCID-Profile: J T Huh, M C Embree
Förderung
- NIDCR NIH HHS
- National Institute of Dental and Craniofacial Research
Zitieren
APA
Huh, J. T., Zheng, A., Kheyfets, B., & Embree, M. C. (2026). Osteoarthritis and Chondrocytes: On the Road from Mechanisms to Treatment. Journal of Dental Research, 105(4), 432-442. https://doi.org/10.1177/00220345251385964
Vancouver
Huh JT, Zheng A, Kheyfets B, Embree MC. Osteoarthritis and Chondrocytes: On the Road from Mechanisms to Treatment. Journal of Dental Research. 2026;105(4):432-442. doi:10.1177/00220345251385964
BibTeX
@article{Huh2026,
author = {Huh, J T and Zheng, A and Kheyfets, B and Embree, M C},
title = {Osteoarthritis and Chondrocytes: On the Road from Mechanisms to Treatment},
journal = {Journal of Dental Research},
year = {2026},
volume = {105},
number = {4},
pages = {432--442},
doi = {10.1177/00220345251385964}
}
EUVIMED